Metro North Health provides vaccination services with Pfizer COVID-19 vaccine (Comirnaty) and AstraZeneca COVID-19 Vaccine across multiple facilities including community clinics, hospital-based clinics and specialist led clinics.
How can your patients get an appointment at a Metro North Health Vaccination Clinic?
Eligible people can now book to receive a COVID-19 vaccine at a Queensland Health vaccination location provided they bring written proof of their eligibility.
Do Metro North Health Vaccination Clinics accept walk-ins?
This will be continually reviewed and updated on our North Health Vaccinations information page which provides a list of all Metro North Health Vaccination Clinics with their opening hours.
Priority will be given to people in the priority groups identified in the Pfizer vaccine drop down list below.
Who are Metro North Health vaccinating?
Metro North Health is vaccinating people aged over 12 years of age based on eligibility for each vaccination below. Identified priority groups will be given priority for vaccination and can be found under Pfizer vaccine drop down below.
This will be continually reviewed and updated on our Metro North Health Vaccinations information page.
Which vaccine is your patient eligible for?
Second dose of your patient’s COVID-19 vaccine
Please note your patient’s second dose of vaccine must match their first dose of vaccine unless they have experienced a significant documented reaction to their first dose or are pregnant.
Which patients should I refer to Qld Adult Specialist Immunisation Service (QASIS)?
The state-wide service (based at Metro North Hospital and Health Service) for those aged over 16 years requiring consideration for hospital-based COVID-19 vaccination for those with significant allergies, anaphylaxis or side effects as listed in criteria below.
- The patient will be reviewed to determine suitability for vaccination. This is usually conducted by phone consult and may be performed by a Senior Medical Officer or Nurse Practitioner, or another medical officer. A senior staff member reviews all cases.
- If the patient lives regionally,
QASIS will assist in identifying suitable locations for vaccination and it will be the responsibility of the patient and referring doctor to coordinate vaccination appointment. If required, QASIS will provide appropriate documentation to support vaccination in regional centres. Referrers should refer to their local Public Health Unit for an up-to-date list of locally operated vaccination centres.
Who should be referred to QASIS
The patient must meet the following to be referred to QASIS:
Anyone who has experienced:
It is also recommended that adults who may be at risk of experiencing an AEFI under the following circumstances are referred to QASIS prior to vaccination:
- Anaphylaxis or generalised allergic reaction (without anaphylaxis) to any component of the COVID-19 vaccine to be administered (including allergic reactions to other vaccines).
- A history of PEG or polysorbate 80 related allergic reactions (include details and dates of the substance that the person reacted to).
- A systemic mast cell activation condition with a raised tryptase that have been unable to tolerate previous intramuscular injections due to recurrent anaphylaxis.
- A history of capillary leak syndrome.
- A history of pericarditis or myocarditis following COVID-19 vaccination
What allergic conditions require a referral to QASIS?
- Individuals who have experienced an immediate (within 2 hours) and generalised symptoms of an allergic reaction following a COVID-19 vaccination.
- A history of anaphylaxis or allergic reaction to any component of a COVID-19 vaccine (e.g. PEG or polysorbate 80)
- A systemic mast cell activation disorder
Who should not be referred to QASIS?
- History of allergy, including anaphylaxis to food, venom or latex. See QASIS recommendation here.
- Allergic conditions including asthma, atopic dermatitis or allergic rhinitis. See QASIS recommendation here.
- History of venous thromboembolism in typical sites (DVT or PE) not related to exposure to a COVID-19 vaccine.
- Predisposition to form blood clots (e.g. Factor V Leiden) or other non-immune thrombophillic disorders.
- Family history of blood clotting disorders or clotting conditions.
- History of congenital cardiac abnormalities. Please consult patients regular cardiologist.
- History of myocarditis or pericarditis not related to the COVID-19 vaccine. See here and consult the patients regular cardiologist.
- Current or past history of thrombocytopenia (low platelet count). See the joint statement from the ATAGI and THANZ here.
- Individuals who experience minor or expected side-effects as outlined in the product information who wish to change to another vaccine. Unless contraindicated as outlined above exist, the advice remains to vaccinate with the same COVID-19 vaccine. See the here for further advice on when a vaccine may be switched.
Please note QASIS does not accept referral requests for a particular vaccine brand. Vaccine eligibility is determined by Commonwealth Guidelines and clinical need.
How do I refer my patient to QASIS?
You must provide a referral to access this service. There is no walk-in available.
Send an outpatient referral to MNHHS Central Patient Intake Unit (CPIU) via:
(For GPs outside Metro North HHS catchment – Medical Objects ID: MQ40290004P or HealthLink EDI is: qldmnhhs)
Referrals must include essential clinical information listed below explaining the reason for referral and details of the condition or reaction that requires hospital review.
As information changes frequently, it is important that you are aware of latest COVID-19 updates.